l-carnitine tmao nature medicine 2013 koeth Unraveling the Formation Mechanisms of Trimethylamine N-Oxide and Its Inhibition by Food Ingredients: Toward Cardioprotective Food Development γ–Butyrobetaine is a pro-atherogenic intermediate
Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC Intestinal microbiota metabolism of L carnitine, a nutrient in red meat, promotes atherosclerosis PMC TMAO (Trimethylamine oxide) biocrates life science Gut Metabolite Trimethylamine N Oxide in Atherosclerosis: From Mechanism to Therapy Frontiers JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Innovative carnitine fed rats model reveals resveratrol butyrate Ester's multimechanistic role in reducing TMAO and cardiovascular risk ScienceDirect
Pay in 4 interest-free payments of $6.38 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4





